Zheng, Y., Song, D., Guo, M., Wang, C., Ma, M., Tao, G., . . . An, Y. EGFR inhibition augments the therapeutic efficacy of the NAT10 inhibitor Remodelin in Colorectal cancer. BMC.
Chicago Style (17th ed.) CitationZheng, Yongbin, et al. EGFR Inhibition Augments the Therapeutic Efficacy of the NAT10 Inhibitor Remodelin in Colorectal Cancer. BMC.
MLA (9th ed.) CitationZheng, Yongbin, et al. EGFR Inhibition Augments the Therapeutic Efficacy of the NAT10 Inhibitor Remodelin in Colorectal Cancer. BMC.
Warning: These citations may not always be 100% accurate.